Mixed chimerism after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia

References

• Bacigalupo A, Passweg J. Diagnosis and treatment of acquired aplastic anemia [J]. Hematol Oncol Clin North Am. 2009;23(2):159–170.
   PubMed Web of Science ®Google Scholar
• Killick S B, Bown N, Cavenagh J, et al. Guidelines for the diagnosis and management of adult aplastic anaemia [J]. Br J Haematol. 2016;172(2):187–207.
   PubMed Web of Science ®Google Scholar
• Dufour C, Pillon M, Passweg J, et al. Outcome of aplastic anemia in adolescence: a survey of the severe aplastic anemia Working Party of the European group for blood and Marrow transplantation [J]. Haematologica. 2014;99(10):1574–1581.
   PubMed Web of Science ®Google Scholar
• Dufour C, Pillon M, Socie G, et al. Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant [J]. Br J Haematol. 2015;169(4):565–573.
   PubMed Web of Science ®Google Scholar
• Ebens C L, Defor T E, Tryon R, et al. Comparable outcomes after HLA-matched sibling and alternative donor hematopoietic cell transplantation for children with Fanconi anemia and severe aplastic anemia [J]. Biol Blood Marrow Transplant. 2018;24(4):765–771.
   PubMed Web of Science ®Google Scholar
• Bacigalupo A, Socie G, Hamladji R M, et al. Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis [J]. Haematologica. 2015;100(5):696–702.
   PubMed Web of Science ®Google Scholar
• Xu L P, Jin S, Wang S Q, et al. Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant [J]. J Hematol Oncol. 2017;10(1):25.
   PubMedGoogle Scholar
• Xu Z L, Zhou M, Jia J S, et al. Immunosuppressive therapy versus haploidentical transplantation in adults with acquired severe aplastic anemia [J]. Bone Marrow Transplant. 2019;54(8):1319–1326.
   PubMed Web of Science ®Google Scholar
• Stikvoort A, Sundin M, Uzunel M, et al. Long-Term stable mixed chimerism after hematopoietic stem cell transplantation in patients with Non-malignant disease, shall We Be tolerant? [J]. PLoS One. 2016;11(5):e0154737.
   PubMed Web of Science ®Google Scholar
• Satwani P, Cooper N, Rao K, et al. Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases [J]. Bone Marrow Transplant. 2008;41(2):173–182.
   PubMed Web of Science ®Google Scholar
• Mccann S, Passweg J, Bacigalupo A, et al. The influence of cyclosporin alone, or cyclosporin and methotrexate, on the incidence of mixed haematopoietic chimaerism following allogeneic sibling bone marrow transplantation for severe aplastic anaemia [J]. Bone Marrow Transplant. 2007;39(2):109–114.
   PubMed Web of Science ®Google Scholar
• Bader P, Niethammer D, Willasch A, et al. How and when should we monitor chimerism after allogeneic stem cell transplantation? [J]. Bone Marrow Transplant. 2005;35(2):107–119.
   PubMed Web of Science ®Google Scholar
• Kong Y, Shi MM, Zhang YY, et al. N-acetyl-L-cysteine improves bone marrow endothelial progenitor cells in prolonged isolated thrombocytopenia patients post allogeneic hematopoietic stem cell transplantation [J]. Am J Hematol. 2018;93(7):931–942.
   PubMed Web of Science ®Google Scholar
• Mattsson J, Ringden O, Storb R. Graft failure after allogeneic hematopoietic cell transplantation [J]. Biol Blood Marrow Transplant. 2008;14(1 Suppl 1):165–170.
   PubMed Web of Science ®Google Scholar
• Shamshad G U, Ahmed S, Bhatti F A, et al. Mixed donor chimerism in non-malignant haematological diseases after allogeneic bone marrow transplantation [J]. J Coll Physicians Surg Pak. 2012;22(12):765–768.
   PubMed Web of Science ®Google Scholar
• Andreani M, Testi M, Lucarelli G. Mixed chimerism in haemoglobinopathies: from risk of graft rejection to immune tolerance [J]. Tissue Antigens. 2014;83(3):137–146.
   PubMedGoogle Scholar
• Lawler M, Mccann S R, Marsh J C, et al. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA [J]. Br J Haematol. 2009;144(6):933–945.
   PubMed Web of Science ®Google Scholar
• Ashizawa M, Akahoshi Y, Nakano H, et al. A combination of fludarabine, half-dose cyclophosphamide, and anti-thymocyte globulin is an effective conditioning regimen before allogeneic stem cell transplantation for aplastic anemia [J]. Int J Hematol. 2014;99(3):311–317.
   PubMed Web of Science ®Google Scholar
• Marsh J C, Ball S E, Cavenagh J, et al. Guidelines for the diagnosis and management of aplastic anaemia [J]. Br J Haematol. 2009;147(1):43–70.
   PubMed Web of Science ®Google Scholar
• Kako S, Kanda Y, Onizuka M, et al. Allogeneic hematopoietic stem cell transplantation for aplastic anemia with pre-transplant conditioning using fludarabine, reduced-dose cyclophosphamide, and low-dose thymoglobulin: A KSGCT prospective study [J]. Am J Hematol. 2020;95(3):251–257.
   PubMed Web of Science ®Google Scholar
• Huss R, Deeg H J, Gooley T, et al. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia [J]. Bone Marrow Transplant. 1996;18(4):767–776.
   PubMed Web of Science ®Google Scholar
• Stern M, Passweg J R, Locasciulli A, et al. Influence of donor/recipient sex matching on outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia [J]. Transplantation. 2006;82(2):218–226.
   PubMed Web of Science ®Google Scholar
• Bacigalupo A, Socie G, Lanino E, et al. Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party [J]. Haematologica. 2010;95(6):976–982.
   PubMed Web of Science ®Google Scholar
• Maury S, Bacigalupo A, Anderlini P, et al. Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen [J]. Haematologica. 2009;94(9):1312–1315.
   PubMed Web of Science ®Google Scholar
• Chaudhry Q UN, Iftikhar R, Satti T M, et al. Outcome of fludarabine-based conditioning in high-risk aplastic anemia patients undergoing matched related donor transplantation: A single-center study from Pakistan [J]. Biol Blood Marrow Transplant. 2019;25(12):2375–2382.
   PubMed Web of Science ®Google Scholar
• Olsson R, Remberger M, Schaffer M, et al. Graft failure in the modern era of allogeneic hematopoietic SCT [J]. Bone Marrow Transplant. 2013;48(4):537–543.
   PubMed Web of Science ®Google Scholar
• Kako S, Yamazaki H, Ohashi K, et al. Mixed chimerism and secondary graft failure in allogeneic hematopoietic stem cell transplantation for aplastic anemia [J]. Biol Blood Marrow Transplant. 2020;26(3):445–450.
   PubMedGoogle Scholar